|Bid||0.7700 x N/A|
|Ask||0.8000 x N/A|
|Day's Range||0.0000 - 0.0000|
|52 Week Range|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||19.75|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Announced that the U.S. Food and Drug Administration has approved the Company’s Investigational New ...
Announced that its wholly-owned subsidiary, PharmaTher has entered into an exclusive license agreement ...
A wholly-owned subsidiary of Newscope Capital Corporation (CSE: PHRM) announced it has entered into ...